| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NANOSTRING TECHNOLOGIES INC | 3,959,440 | 49,889,000 | 43.65% | ||
| 2 | Oxford Immunotec Global PLC | 2,153,092 | 19,378,000 | 16.95% | ||
| 3 | SIENTRA INC | 2,730,765 | 17,968,000 | 15.72% | ||
| 4 | VBI VACCINES INC COM NEW | 2,691,042 | 10,630,000 | 9.30% | ||
| 5 | Catabasis Pharmaceuticals Inc | 2,752,488 | 10,184,000 | 8.91% | ||
| 6 | ESSA Pharma | 2,121,212 | 6,257,000 | 5.47% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001431431-16-000003, filed 2016.08.04).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
